Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Novel Laboratories, Inc. d.b.a Lupin Somerset.
Novel Laboratories, Inc. d.b.a Lupin Somerset: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Novel Laboratories, Inc. d.b.a Lupin Somerset — Warning letters0
Philips North America — Warning letters0
Novel Laboratories, Inc. d.b.a Lupin Somerset — Recalls0
Philips North America — Recalls355
Novel Laboratories, Inc. d.b.a Lupin Somerset — Approval records0
Philips North America — Approval records0
Novel Laboratories, Inc. d.b.a Lupin Somerset — Form 483s1
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Novel Laboratories, Inc. d.b.a Lupin Somerset vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 17, 2026. https://argushq.ai/compare/novel-laboratories-inc-d-b-a-lupin-somerset-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗